Mathematical modeling involves the use of mathematical equations and relationships to represent biological phenomena. Complementary to this type of modeling is the use of computer simulations to represent these modeling approaches in multiple dimensions. These approaches serve two purposes. First, they provide a basic framework for the interrogation and integration of data, often providing insight into the type and quality needed for addressing a hypothesis or experimental design. This feature is especially useful when trying to integrate or analyze the large datasets generally associated with systems biology. Second, and more importantly, these models or simulations should allow one to predict the biological state under investigation and predict how the natural process will behave in various circumstances. These problems center on the understanding of the behavior of biological systems whose function is governed by the spatial and temporal ordering of multiple interacting components at the molecular, cellular, and tissue levels. We will also develop bioinformatics and bioimaging models to integrate and analyze the data generated from Component 1, and make use of the information obtained from data analysis, biological knowledge to build in silico models to model TIC behavior, cancer cell apoptosis, cell migration, cell cycle changes and drug treatment response. The goal of this component is to take advantage of our combined expertise in cell biology and computational modeling to develop coherent experimental protocols and construct biomathematical models for understanding the mechanism underiying breast cancer stem cell evolution, i.e., how one stem cell evolves into breast tumor with various sizes and compositions in cell microenvironment. Our hypothesis is that that TIC behavior during tumor development can be simulated using a robust, multiscale mathematical/computational model of TIC behavior during breast cancer development. Further, that these models can be built to reflect not only the molecular, cellular, and tissue-level dynamics, but also to allow prediction of the response of TIC to experimental therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA149196-05
Application #
8628782
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
5
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Methodist Hospital Research Institute
Department
Type
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77030
Leung, Cecilia S; Yeung, Tsz-Lun; Yip, Kay-Pong et al. (2018) Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance. J Clin Invest 128:589-606
Wang, Hai; Tian, Lin; Liu, Jun et al. (2018) The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability. Cancer Cell 34:823-839.e7
Yu, Yaping; Kong, Ren; Cao, Huojun et al. (2018) Two birds, one stone: hesperetin alleviates chemotherapy-induced diarrhea and potentiates tumor inhibition. Oncotarget 9:27958-27973
Liu, Yi; Choi, Dong Soon; Sheng, Jianting et al. (2018) HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway. Stem Cell Reports 10:212-227
Rosato, Roberto R; Dávila-González, Daniel; Choi, Dong Soon et al. (2018) Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models. Breast Cancer Res 20:108
Ren, Ding; Zhu, Xiaoping; Kong, Ren et al. (2018) Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer. Cancer Res 78:2052-2064
Guven, Adem; Villares, Gabriel J; Hilsenbeck, Susan G et al. (2017) Carbon nanotube capsules enhance the in vivo efficacy of cisplatin. Acta Biomater 58:466-478
Chen, Suyun; Ibrahim, Nuhad K; Yan, Yuanqing et al. (2017) Complete Metabolic Response on Interim18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy. Oncologist 22:526-534
Neelakantan, Deepika; Zhou, Hengbo; Oliphant, Michael U J et al. (2017) EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells. Nat Commun 8:15773
Liang, Diana H; Choi, Dong Soon; Ensor, Joe E et al. (2016) The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer Lett 376:249-58

Showing the most recent 10 out of 106 publications